Publicaciones en las que colabora con Laida Elberdín Pazos (6)

2022

  1. Biologic Therapy for Moderate to Severe Psoriasis. Real-World Follow-up of Patients Who Initiated Biologic Therapy at Least 10 Years Ago

    Dermatology and Therapy, Vol. 12, Núm. 3, pp. 761-770

  2. Real-world use of ustekinumab therapeutic drug monitoring in moderate to severe psoriasis

    Frontiers in Medicine, Vol. 9

2020

  1. Ustekinumab treatment for moderate to severe psoriasis. Eight-year real-world follow-up of 61 cases in a tertiary level hospital

    Journal of Dermatological Treatment, Vol. 31, Núm. 7, pp. 698-701

2016

  1. Positive correlation between etanercept concentration and the decrease in Psoriasis Area and Severity Index scale value

    International Journal of Clinical Pharmacy, Vol. 38, Núm. 5, pp. 1142-1148

2015

  1. Efficacy and safety of adalimumab in psoriatic patients previously treated with etanercept in a real-world setting

    Journal of Dermatological Treatment, Vol. 26, Núm. 3, pp. 217-222

  2. Infliximab drug and antibody levels in patients with dermatological conditions

    International Journal of Clinical Pharmacy, Vol. 37, Núm. 2, pp. 320-326